Signaling from the proton-activated cell-surface receptor TDAG8 was rewired into a cAMP-sensitive response element operated by CREB1 for the expression of transgenes, including insulin for the treatment of diabetes-associated ketoacidosis. This evidence concerns the gene CREB1 and diabetes mellitus.